CVS Caremark, Rhode Island Free Clinic partner to help underserved Rhode Islanders
PROVIDENCE, R.I. — CVS Caremark and the Rhode Island Free Clinic have announced a partnership to help the uninsured, working poor in Rhode Island get access to the vital medications they need. Through this collaboration, the clinic’s patients can get prescriptions filled at no cost, and can receive face-to-face pharmacist counseling at three CVS/pharmacy locations in the greater Providence area.
“We are so appreciative of this invaluable partnership with CVS Caremark,” stated Marie Ghazal, CEO of the Rhode Island Free Clinic. “We provide free, comprehensive health care to approximately 2,000 uninsured Rhode Islanders each year, and this partnership will provide them with increased access and expert counsel for the medications they need.” Prior to the partnership, the clinic relied on dozens of pharmacists and pharmacy technicians who were donating their time to fill the nearly 15,000 prescriptions needed by patients each year.
CVS Caremark began partnering with the Rhode Island Free Clinic in 2010 when the company awarded the clinic a $50,000 grant from its Foundation — the CVS Caremark Charitable Trust — to help cover the costs of prescriptions needed by the clinic’s patients. As the number of patients that the clinic was serving increased, the clinic became concerned about maintaining the quality of their pharmacy program and reached out to CVS Caremark for an innovative solution to this growing need.
“At CVS Caremark, we have a strong philanthropic focus on providing access to quality health care to underserved populations, making our work with the Rhode Island Free Clinic a natural fit,” stated Larry Merlo, president and CEO of CVS Caremark. “This partnership allows us to help Rhode Islanders on their path to better health by connecting them with our pharmacists who can provide counseling and support.”
Merlo noted that the enhanced offerings of the partnership will also allow the clinic to prioritize their limited resources and focus on providing quality healthcare services to Rhode Islanders who need it most.
Through the strengthened partnership between CVS Caremark and the Rhode Island Free Clinic, patients of the clinic can get their prescriptions filled at no cost at three CVS/pharmacy locations in the state. These locations, requested by the clinic based on where their patients live, include CVS/pharmacy stores at 309 Broad Street in Central Falls, 1195 Oaklawn Avenue in Cranston and 960 Broad Street in Providence.
Prestige Brands launches Goody’s caplets
IRVINGTON, N.Y. — Prestige Brands on Monday announced the launch of Goody’s in a caplet format. The pain reliever had long been sold as a powder.
“Goody’s Extra Strength and Migraine Relief caplets are fast solutions for those seeking extra strength or migraine relief options in the current market place,” stated Joseph Juliano, brand director for Goody’s. “We’ve heard time and time again that loyal Goody’s users love the fast pain relief of Goody’s powder. With the introduction of Goody’s caplets, we are excited that new pain and migraine sufferers can experience the fast relief of Goody’s.”
Goody’s Extra Strength and Goody’s Migraine Relief Caplets contain the same active ingredients as Excedrin Extra Strength and Excedrin Migraine, competing pain products not currently available for purchase, Prestige Brands noted.
Sanofi Pasteur hosts flu shot tour at Seattle Walgreens
SWIFTWATER, Pa. — Sanofi Pasteur is bringing its Fluzone Intradermal Vaccine Coop de Quill VacciNation Tour to Seattle Monday as part of its cross-country efforts to raise awareness about the seriousness of influenza and the various vaccine options that are available for adults 18 through 64 years old this flu season.
In an effort to help improve flu immunization rates, Sanofi Pasteur’s Fluzone Intradermal Vaccine Coop de Quill VacciNation Tour will visit the Kirkland Walgreens for a flu clinic event.
Only 36% of adults in Washington 18 through 64 years of age were immunized during the 2010-2011 flu season, Sanofi noted. Results from a recent national telephone survey of 663 adults revealed these low rates highlight a disconnect between fear and action, as 2-out-of-every-3 (67%) adults 18 through 64 years of age said if they had influenza, they fear spreading the virus to their loved ones, yet 3-in-5 (61%) adults said they are not vaccinated annually.
The Coop de Quill vehicle, which features a supersized rooftop 3D structure of the Fluzone Intradermal vaccine and with which attendees can interact will be on site.